Market Overview:
MicroRNA reverse transcription is the process of converting microRNA molecules into complementary DNA (cDNA) strands. This technology has revolutionized the field of molecular biology by allowing researchers to study the function and regulation of microRNAs. The global market for microRNA reverse transcription is expected to grow at a CAGR of 10.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for kits, reagents, and instruments used in microRNA reverse transcription research, and the growing prevalence of cancer, kidney disease, neurological disease, and cardiovascular disease. The global market for microRNA reverse transcription is segmented on the basis of type into instruments, kits & reagents, and consumables. The instruments segment is expected to account for the largest share of this market in 2018 owing to its growing use in research laboratories worldwide. On the basis of application, this market is segmented into cancer research; kidney disease research; neurological disease research; cardiovascular disease research; and other applications such as diabetes mellitusresearchand stem cell therapyresearch .
Product Definition:
MicroRNA Reverse Transcription is the process of converting MicroRNAs (miRNAs) into genetic sequences known as cDNAs. This process is important because it allows scientists to study the functions of miRNAs and how they interact with other genes.
Instruments:
Instruments, it's usage.
The global instruments, it's usage and growth factor in microRNA (miRNA) reverse transcription market size was valued at USD 21.5 million in 2015. It is expected to expand at a CAGR of XX% over the forecast period.
Kits & Reagents:
Kits & reagents are used for the process of reverse transcription from the DNA or RNA to make cDNA. The steps involved in this process are important for gene expression studies. It comprises of four major components, which are enzymes, primers, probes and salts.
The usage of kits and reagents is increasing due to its cost effectiveness.
Application Insights:
Cancer was the largest application segment in the global market and accounted for a revenue share of over 40% in 2017. Cancer is one of the most common diseases worldwide. MicroRNA expression profiles have been proved to be useful in cancer diagnostics and prognosis. Therefore, increasing research on microRNA expression during tumorigenesis, metastasis, drug resistance and development is expected to boost growth during the forecast period.
The kidney disease segment held a significant revenue share owing to an increase in prevalence rate of chronic kidney diseases (CKDs) worldwide due largely to unhealthy lifestyle such as excessive drinking & eating habits coupled with obesity which has resulted into increased incidence rate of CKD across all age groups globally which is anticipated to fuel demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D and easy availability of resources for clinical trials. Moreover, increasing prevalence of chronic diseases is also expected to drive regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising awareness about advanced technologies and growing focus on drug discovery & development activities by various companies present in this region as well as from other regions. Availability of skilled labor at low cost along with technological advancements are some additional factors that have contributed significantly toward regional growth over past few years (Bhalla et al., 2018).
Moreover, government initiatives such as “Make in India†initiative by Indian government has attracted many pharmaceutical companies which are looking for sources for raw material and components required for manufacturing drugs; thus driving overall demand across this region (Kumar & Srivastava, 2016).
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of cancer and other diseases
- Growing application of microRNA in drug discovery and development processes
- Technological advancements in microRNA reverse transcription assay platforms
- Rising investments by pharmaceutical and biotechnology companies for R&D activities
Scope Of The Report
Report Attributes
Report Details
Report Title
MicroRNA Reverse Transcription Market Research Report
By Type
Instruments, Kits & Reagents, Consumables
By Application
Cancer, Kidney Disease, Neurological Disease, Cardiovascular Disease, Others
By Companies
Sigma Aldrich Corp., Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc., New England Biolabs, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global MicroRNA Reverse Transcription Market Report Segments:
The global MicroRNA Reverse Transcription market is segmented on the basis of:
Types
Instruments, Kits & Reagents, Consumables
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Kidney Disease, Neurological Disease, Cardiovascular Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sigma Aldrich Corp.
- Thermo Fisher Scientific
- Agilent Technologies
- Illumina, Inc.
- Bio-Rad Laboratories Inc.
- System Biosciences LLC
- HTG Molecular Diagnostics, Inc.
- GeneCopoeia, Inc.
- New England Biolabs, Inc.
Highlights of The MicroRNA Reverse Transcription Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Kits & Reagents
- Consumables
- By Application:
- Cancer
- Kidney Disease
- Neurological Disease
- Cardiovascular Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the MicroRNA Reverse Transcription Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MicroRNA reverse transcription is a process by which microRNAs are transcribed from their 5' end to their 3' end. This process allows researchers to identify and study the function of microRNAs.
Some of the major companies in the microrna reverse transcription market are Sigma Aldrich Corp., Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc., New England Biolabs, Inc..
The microrna reverse transcription market is expected to register a CAGR of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 MicroRNA Reverse Transcription Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 MicroRNA Reverse Transcription Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 MicroRNA Reverse Transcription Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the MicroRNA Reverse Transcription Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global MicroRNA Reverse Transcription Market Size & Forecast, 2018-2028
4.5.1 MicroRNA Reverse Transcription Market Size and Y-o-Y Growth
4.5.2 MicroRNA Reverse Transcription Market Absolute $ Opportunity
Chapter 5 Global MicroRNA Reverse Transcription Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 MicroRNA Reverse Transcription Market Size Forecast by Type
5.2.1 Instruments
5.2.2 Kits & Reagents
5.2.3 Consumables
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global MicroRNA Reverse Transcription Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 MicroRNA Reverse Transcription Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Kidney Disease
6.2.3 Neurological Disease
6.2.4 Cardiovascular Disease
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global MicroRNA Reverse Transcription Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 MicroRNA Reverse Transcription Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America MicroRNA Reverse Transcription Analysis and Forecast
9.1 Introduction
9.2 North America MicroRNA Reverse Transcription Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America MicroRNA Reverse Transcription Market Size Forecast by Type
9.6.1 Instruments
9.6.2 Kits & Reagents
9.6.3 Consumables
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America MicroRNA Reverse Transcription Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Kidney Disease
9.10.3 Neurological Disease
9.10.4 Cardiovascular Disease
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe MicroRNA Reverse Transcription Analysis and Forecast
10.1 Introduction
10.2 Europe MicroRNA Reverse Transcription Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe MicroRNA Reverse Transcription Market Size Forecast by Type
10.6.1 Instruments
10.6.2 Kits & Reagents
10.6.3 Consumables
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe MicroRNA Reverse Transcription Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Kidney Disease
10.10.3 Neurological Disease
10.10.4 Cardiovascular Disease
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific MicroRNA Reverse Transcription Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific MicroRNA Reverse Transcription Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific MicroRNA Reverse Transcription Market Size Forecast by Type
11.6.1 Instruments
11.6.2 Kits & Reagents
11.6.3 Consumables
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific MicroRNA Reverse Transcription Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Kidney Disease
11.10.3 Neurological Disease
11.10.4 Cardiovascular Disease
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America MicroRNA Reverse Transcription Analysis and Forecast
12.1 Introduction
12.2 Latin America MicroRNA Reverse Transcription Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America MicroRNA Reverse Transcription Market Size Forecast by Type
12.6.1 Instruments
12.6.2 Kits & Reagents
12.6.3 Consumables
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America MicroRNA Reverse Transcription Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Kidney Disease
12.10.3 Neurological Disease
12.10.4 Cardiovascular Disease
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) MicroRNA Reverse Transcription Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) MicroRNA Reverse Transcription Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) MicroRNA Reverse Transcription Market Size Forecast by Type
13.6.1 Instruments
13.6.2 Kits & Reagents
13.6.3 Consumables
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) MicroRNA Reverse Transcription Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Kidney Disease
13.10.3 Neurological Disease
13.10.4 Cardiovascular Disease
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 MicroRNA Reverse Transcription Market: Competitive Dashboard
14.2 Global MicroRNA Reverse Transcription Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sigma Aldrich Corp.
14.3.2 Thermo Fisher Scientific
14.3.3 Agilent Technologies
14.3.4 Illumina, Inc.
14.3.5 Bio-Rad Laboratories Inc.
14.3.6 System Biosciences LLC
14.3.7 HTG Molecular Diagnostics, Inc.
14.3.8 GeneCopoeia, Inc.
14.3.9 New England Biolabs, Inc.
